2. Gene
  3. Sirt3 - sirtuin 3 Gene

Sirt3 - sirtuin 3 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Mus musculus

Also known as Sir2l3; 2310003L23Rik

Gene ID: 64384 | Gene type: protein coding

About Sirt3

Chromosome 7: 140,443,579-140,462,222 reverse strand.GRCm39:CM001000.3

This gene has 10 transcripts (splice variants), 198 orthologues, 6 paralogues and is associated with 36 phenotypes. Ubiquitous expression in kidney adult (RPKM 35.3), liver adult (RPKM 33.7) and 28 other tissues.

Summary

Enables NAD-dependent histone deacetylase activity (H3-K14 specific) and sequence-specific DNA binding activity. Involved in peptidyl-lysine deacetylation; positive regulation of ceramide biosynthetic process; and positive regulation of mitochondrial transcription. Acts upstream of or within negative regulation of peptidyl-lysine acetylation and protein deacetylation. Located in mitochondrial inner membrane and mitochondrial matrix. Part of protein-containing complex. Is expressed in several structures, including brain; branchial arch; endocrine gland; genitourinary system; and liver and biliary system. Used to study abdominal obesity-metabolic syndrome. Orthologous to human SIRT3 (Sirtuin 3). [provided by Alliance of Genome Resources, Apr 2022]

Sirt3 Products(3)

mRNA Protein Name
NM_022433.2 NP_071878.2 NAD-dependent protein deacetylase sirtuin-3 isoform 1
NM_001177804.1 NP_001171275.1 NAD-dependent protein deacetylase sirtuin-3 isoform 3
NM_001127351.1 NP_001120823.1 NAD-dependent protein deacetylase sirtuin-3 isoform 1

Sirt3 Protein Structure

SIRT1

SIRT1: cd01408 (0 - 230)

  • 0
  • 100
  • 200
  • 257 a.a.
Protein Preferred Names Protein Names

NAD-dependent protein deacetylase sirtuin-3

NAD-dependent deacetylase sirtuin-3

SIR2-like protein 3

SIRT3L mitochondrial

mSIR2L3

mitochondrial protein lysine deacetylase

regulatory protein SIR2 homolog 3

silent mating type information regulation 2, (S.cerevisiae, homolog)-like 3

Related Agents

Approval
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0130A Perindopril erbumine 99.98% Yes
HY-B0130 Perindopril 98.01% Yes
Clinical Phase
Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-123033A Nicotinamide riboside chloride Activator 99.59% Phase 4
HY-123033 Nicotinamide riboside Activator / Phase 4
HY-123033B Nicotinamide riboside tartrate Activator / Phase 4
HY-123033C Nicotinamide riboside malate Activator / Phase 4
Pre-clinical Phase
Bioactive Molecules (17)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-108331 3-TYP Inhibitor 99.90% Unkown
HY-100578 AGK2 Inhibitor 99.62% Unkown
HY-15510 Tenovin-6 Inhibitor 98.33% Unkown
HY-N6675 Gardenia yellow Activator / Unkown
HY-136199 SIRT1-IN-1 Inhibitor 98.19% Unkown
HY-16616 SIRT-IN-2 Inhibitor 98.08% Unkown
HY-15510B Tenovin-6 Hydrochloride Inhibitor ≥98.0% Unkown
HY-16615 SIRT-IN-1 Inhibitor 98.58% Unkown
HY-151519 SIRT2-IN-9 Inhibitor 99.45% Unkown
HY-N2673 5-Heptadecylresorcinol Activator ≥98.0% Unkown
HY-111329 JGB1741 Inhibitor 99.05% Unkown
HY-111303 CHIC35 Inhibitor / Unkown
HY-155784 SPC-180002 Inhibitor / Unkown
HY-160617 SIRT2-IN-14 Inhibitor / Unkown
HY-146013 Sirt1/2-IN-1 Inhibitor / Unkown
HY-150727 SIRT5 inhibitor 4 Inhibitor / Unkown
HY-118343 AC-93253 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Sirt3 NCBI NCBI:23410